For research use only. Not for therapeutic Use.
Zelquistinel (AGN-241751) is a N-methyl-D-aspartate (NMDA) receptor partial agonist used for the research of depression, anxiety and other related psychiatric disorders[1].
| Catalog Number | I038678 |
| CAS Number | 2151842-64-5 |
| Synonyms | tert-butyl (4S)-2-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-3-oxo-2,5-diazaspiro[3.4]octane-5-carboxylate |
| Molecular Formula | C15H25N3O5 |
| Purity | ≥95% |
| InChI | InChI=1S/C15H25N3O5/c1-9(19)10(11(16)20)17-8-15(12(17)21)6-5-7-18(15)13(22)23-14(2,3)4/h9-10,19H,5-8H2,1-4H3,(H2,16,20)/t9-,10+,15+/m1/s1 |
| InChIKey | ABAPCYNTEPGBNJ-FTGAXOIBSA-N |
| SMILES | CC(C(C(=O)N)N1CC2(C1=O)CCCN2C(=O)OC(C)(C)C)O |
| Reference | [1]. Khan, M. Amin, et al.Preparation of spiro-lactams as NMDA receptor modulators and uses thereof.WO2017201283A1 |
